ADAMTS13 and thrombotic thrombocytopenic purpura: Animal models of antibody‐mediated acquired TTP have been developed by inducing ADAMTS‐13 deficiency in mice, rats and baboons by the use of inhibitory mAbs 63, 85, 86.